Fexofenadine in Patients With Active Rheumatoid Arthritis

Clinical trial NCT05264025 · RECRUITING

Trial details

NCT number: NCT05264025
Sponsor: October 6 University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2022-06-01
Primary completion: 2025-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.